Latest Breaking News On - Michiel van der heijden research group - Page 1 : comparemela.com

Survival Benefits with Keytruda and Padcev in Advanced Urothelial Cancer

Patients with previously untreated locally advanced or metastatic urothelial carcinoma experienced favorable progression-free survival, overall survival and objective response rates when treated with Padcev and Keytruda versus chemotherapy.